Remove Compound Screening Remove Engineer Remove Gene Editing Remove Genome
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

At the height of the pandemic, DCTs were seen as a viable alternative to keeping the engines running on clinical trials when non-critical in-person care was paused. Opportunities will progress for use cases such as cancer diagnoses based on liquid biopsies, predicting cancer progression and improving gene editing tools potential (e.g.